Clinical trial · Observational
Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination
NCT04909814CI-TRIAL-00052124completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Women were invited to attend colposcopy within two-four months after a positive screening test (two consecutive screening tests indicating low-grade squamous intraepithelial lesions (LSIL) and HPV positivity or a single screening test indicating high grade squamous intraepithelial lesions (HSIL)), according to national guidelines
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| HPV | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| The performance of colposcopy in vaccinated women | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Vaccinated women with positive screening test
- description
- All women in one Swedish county taking their first screening test within the organized cervical screening program
- interventionNames
- Biological: The performance of colposcopy in vaccinated women
Primary outcomes (1)
- measure
- Performance of the Swedscore colposcopy scale in HPV-vaccinated women
- timeFrame
- 1 year
- description
- Positive predictive value of colposcopy for high grade lesions in HPV-vaccinated women
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 22 Years
- Maximum age
- 26 Years
Show eligibility criteria text
Inclusion Criteria: \- HPV-vaccinated women Women taking their first test within the organized cervical screening program at age 23 Women residing in one Swedish county Exclusion Criteria: Women who were hysterectomized, Women who died Women who moved \-
References
Publications (1)
- DERIVEDSahlgren HAI, Elfgren K, Sparen P, Elfstrom MK. Colposcopic performance in a birth cohort previously eligible for human papillomavirus vaccination. Am J Obstet Gynecol. 2022 May;226(5):704.e1-704.e9. doi: 10.1016/j.ajog.2021.11.1372. Epub 2021 Dec 23. PMID 34954217